Baby | DC* 10 μV at 24 h | DC* 15 μV at 24 h | BGT | PLIC | White matter | Seizure burden† | Neurodevelopmental outcome |
---|---|---|---|---|---|---|---|
1 | 0 | 0 | Mild | Normal | Mild | None | Normal |
2 | 0 | 0 | Mild | Normal | Moderate | None | Normal |
3 | 0 | 0 | Mild | Normal | Moderate | None | Normal |
4 | 0 | 0 | Mild | Normal | Normal | None | Normal |
5 | 0 | 0 | Mild | Normal | Mild | None | Normal |
6 | 0 | 0 | Mild | Normal | Normal | Low | Normal |
7 | 0 | 0 | Normal | Normal | Mild | Low | Normal |
8 | 0 | 0 | Mild | Normal | Mild | None | Normal |
9 | 0 | 0 | Mild | Normal | Moderate | None | Bilateral SN hearing loss |
10 | 0 | 0 | Normal | Normal | Normal | None | n/a |
11 | 0 | 0 | Normal | Normal | Normal | None | n/a |
12 | 0 | 0.1 | Normal | Normal | Normal | None | Normal |
13 | 0 | 0.2 | Mild | Normal | Normal | None | Normal |
14 | 0 | 0.2 | Normal | Normal | Severe | High | Normal |
15 | 0 | 0.2 | Mild | Normal | Moderate | High | Normal |
16 | 0 | 0.2 | Mild | Normal | Moderate | Low | Seizures and unilateral hearing loss |
17 | 0 | 1.2 | Normal | Normal | Mild | None | Normal |
18 | 0 | 3.3 | Moderate | Partially Impaired | Severe | High | Normal |
19 | 0 | 21.5 | Mild | Normal | Moderate | High | Normal |
20 | 0.1 | 0.8 | Moderate | Normal | Severe | High | Mild speech delay |
21 | 0.1 | 1.8 | Mild | Normal | Normal | None | Normal |
22 | 0.1 | 12.5 | Normal | Normal | Normal | None | Normal |
23 | 0.2 | 1.7 | Mild | Normal | Mild | None | n/a |
24 | 0.2 | 3.3 | Mild | Normal | Mild | High | Normal |
25 | 0.3 | 18.6 | Normal | Partially Impaired | Normal | None | Normal |
26 | 0.6 | 3.5 | Moderate | Normal | Mild | None | Normal |
27 | 0.6 | 9.9 | Normal | Normal | Mild | Low | Normal |
28 | 0.9 | 11.1 | Severe | Severely Impaired | Severe | High | Dyskinetic CP |
29 | 1.2 | 8.6 | Normal | Normal | Severe | High | Normal |
30 | 2.4 | 16 | Moderate | Normal | Moderate | None | n/a |
31 | 2.4 | 18.5 | Normal | Normal | Normal | Low | Bilateral SN hearing loss, significant receptive and expressive speech delay |
32 | 2.9 | 9.4 | Mild | Normal | Moderate | None | Normal |
33 | 3.6 | 9.3 | Mild | Normal | Mild | High | Normal |
34 | 4.8 | 24.3 | Normal | Normal | Normal | Low | n/a |
35 | 5 | 19.6 | Mild | Normal | Mild | High | Mild delay |
36 | 7.4 | 23.3 | Mild | Normal | Mild | Low | Normal |
37 | 7.9 | 18.8 | Moderate | Severely Impaired | Mild | None | Normal |
38 | 25.2 | 47.3 | Normal | Normal | Mild | Low | n/a |
39 | 27.7 | 50.4 | Mild | Normal | Mild | High | Normal |
40 | 31.2 | 43.5 | Severe | Severely Impaired | Moderate | Low | Quadriplegic CP |
41 | 47.3 | 50.3 | Moderate | Severely Impaired | Mild | High | Spastic quadriplegic CP, GDD, SN hearing loss and dystonia |
42 | 49.2 | 54.4 | Severe | Severely Impaired | Moderate | High | GDD, microcephaly, visual impairment, dystonia with epilepsy and GORD |
43 | 51.4 | 56.5 | Severe | Severely Impaired | Moderate | High | Quadriplegic CP |
44 | 51.8 | 56 | Severe | Severely Impaired | Severe | Low | Died |
45 | 54.5 | 58 | Moderate | Severely Impaired | Severe | High | Global speech delay, autism and seizures |
46 | 55.3 | 57.9 | Moderate | Severely Impaired | Moderate | High | Died |
47 | 58.6 | 59.9 | Severe | Severely Impaired | Moderate | Low | Died |
48 | 58.9 | 59.7 | Mild | Partially Impaired | Normal | High | Died |
49 | 59.4 | 59.5 | Severe | Severely Impaired | Moderate | High | Spastic quadriplegic CP |
*DC: Discontinuity (at stated threshold and time epoch).
†Low seizure burden includes either no or sporadic seizures; high seizure burden includes either frequent seizures or status epilepticus.
BGT, basal ganglia and thalami; CP, cerebral palsy; GDD, global developmental delay; GORD, gastro-oesophageal reflux disease; PLIC, posterior limb of the internal capsule; SN, sensorineural.